A Synageva Board Member’s Trusts Bought Shares

Page 1 of 2

Trusts related to Board of Directors member Thomas Tisch purchased about 21,000 shares of Synageva Biopharma Corp (NASDAQ:GEVA) on January 9th at an average price of $47.53 per share. Tisch and these trusts now own about 750,000 shares, but any increased exposure at all to the company is of questionable wisdom. Insiders are already exposed to company-specific events which can hurt them economically, and so for the trust to purchase more shares would likely reflect high confidence that the stock price will increase in the future. This is one explanation for why insider purchases tend to be bullish signals (see our analysis of studies on insider trading). Our database of insider trading filings last recorded purchases related to Tisch in July 2012 at $41.20 per share.

Ken Griffin CITADEL INVESTMENT GROUP

Synageva is a biotech company whose primary product would be used to treat patients with lysosomal acid lipase (LAL) deficiency. Since the company is mostly in the development stage, it has been unprofitable and is expected to show net losses in 2013 as well, but the market’s perception of its potential has carried it to a market capitalization of $1.2 billion. The stock is up 300% since shortly after its initial public offering in July 2011. At the end of September, Synageva had about $230 million in cash and cash equivalents on its balance sheet, as opposed to $14 million in total liabilities and $17 million in cash used in the first nine months of 2012. As a result we wouldn’t be worried about the company’s cash needs for at least a few more years. We would note that the most recent data has 16% of the outstanding shares held short.

Synageva was one of the top stock picks of Baker Brothers Advisors, a healthcare focused fund, at the end of September. According to the fund’s 13F, it had 8.4 million shares in its portfolio at that time- a 12% increase from three months earlier (find more of Baker Brothers’ favorite stocks). Felix Baker, who co-manages the fund, currently serves on Synageva’s Board of Director. However, the rest of the hedge fund community was cool on Synageva: very few other funds reported positions, while billionaires Ken Griffin and Steve Cohen had their hedge funds sell their shares. Check out which stocks Griffin’s Citadel and Cohen’s SAC Capital liked instead.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!